Home › Stocks › HLXA

HLXA — MOONLAKE IMMUNOTHERAPEUTICS

Reported value held$45.12M
Funds holding (latest)12
Sector—

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

HLXA (MOONLAKE IMMUNOTHERAPEUTICS) is tracked on HoldingsHub across five years of quarterly 13F filings. 12 funds have reported positions historically, with the sum of their latest reported stakes valued at $45.12M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.

Major shareholders of MOONLAKE IMMUNOTHERAPEUTICS (HLXA) include Fidelity Management & Research (FMR), Citadel Advisors, T. Rowe Price Associates, ranked by reported 13F value among the 12 institutional holders on this page.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2025 1 181.60K $1.30M +0.0%
Q2 2025 1 181.60K $8.57M +5.8%
Q1 2025 1 171.60K $6.70M +0.0%
Q4 2024 1 171.60K $9.29M +3.0%
Q3 2024 1 166.60K $8.40M +0.0%
Q2 2024 1 166.60K $7.33M +0.0%
Q1 2024 1 166.60K $8.37M —
Q1 2022 6 2.95M $32.69M -2.5%

Over the 8 quarters shown, institutional share counts decreased 94% in aggregate (Q1 2022 → Q3 2025); the largest single-quarter swing was Q2 2025 (+5.8%).

Top Institutional Holders (Q3 2025) — 1 funds

FundSharesValuePortfolio WeightChange
Decheng Capital LLC 181.60K $1.30M 0.23% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2025 — 1 funds

FundSharesValuePortfolio WeightChange
Decheng Capital LLC 181.60K $8.57M 2.17% Add

Q1 2025 — 1 funds

FundSharesValuePortfolio WeightChange
Decheng Capital LLC 171.60K $6.70M 1.88% Hold

Q4 2024 — 1 funds

FundSharesValuePortfolio WeightChange
Decheng Capital LLC 171.60K $9.29M 1.99% Add

Q3 2024 — 1 funds

FundSharesValuePortfolio WeightChange
Decheng Capital LLC 166.60K $8.40M 1.99% Hold

Q2 2024 — 1 funds

FundSharesValuePortfolio WeightChange
Decheng Capital LLC 166.60K $7.33M 2.25% Hold

New Positions (latest)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 12 funds)

FundQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q1 2022Q4 2021Q3 2021Q2 2021Q4 2020
Decheng Capital LLC 181.60K 181.60K 171.60K 171.60K 166.60K 166.60K 166.60K — — — — —
Point72 Asset Management — — — — — — — — — — — 70.00K
D. E. Shaw & Co — — — — — — — 337.02K 337.02K 40.05K — —
Marshall Wace — — — — — — — — 532.90K — — —
Millennium Management — — — — — — — 148.22K 55.73K 55.73K — —
T. Rowe Price Associates — — — — — — — 566.19K 746.86K 756.30K — —
UBS Group AG — — — — — — — 1.69K — — — —
Wellington Management Group — — — — — — — — — 483.89K — —
Citadel Advisors — — — — — — — 698.90K 685.94K 685.94K — —
Fidelity Management & Research (FMR) — — — — — — — 1.19M 1.19M — — —
Morgan Stanley — — — — — — — — 13.45K 13.45K — —
Janus Henderson Group — — — — — — — — — 15.17K 48.26K —

Download holders (CSV)

FAQ

Which funds hold HLXA?

12 funds have reported positions in HLXA across five years of 13F filings; the sum of their latest reported stakes is $45.12M.

Who are the top institutional holders of HLXA?

The largest 13F holders are Fidelity Management & Research (FMR), Citadel Advisors, T. Rowe Price Associates, Marshall Wace, Wellington Management Group; the top 25 are ranked at the top of this page.

Who are the major shareholders of MOONLAKE IMMUNOTHERAPEUTICS?

The major shareholders of MOONLAKE IMMUNOTHERAPEUTICS (HLXA) by reported 13F value are Fidelity Management & Research (FMR), Citadel Advisors, T. Rowe Price Associates, Marshall Wace, Wellington Management Group, among 12 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own HLXA" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/HLXA/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →